Ideas

Natural product-derived combinatorial therapy for functional recovery after Myocardial Infarction and prevent cardiac failure: A pharmaceutical mixture encompassing Gambogic acid (GA) and (-)-EpiGalloCatechin-3-Gallate (EGCG) [GA+EGCG] inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, Telomerase & MiR-199,  8/June/2019, 12.06 am
Natural product-derived combinatorial therapy for functional recovery after Myocardial Infarction and prevent cardiac failure: A pharmaceutical mixture encompassing Gambogic acid (GA) and (-)-EpiGalloCatechin-3-Gallate (EGCG) [GA+EGCG] inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, Telomerase & MiR-199,  8/June/2019, 12.06 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of Nature,  by Prof Dimmler, Boon, and others. What we…

read more

Molecular therapy for body weight control, energy homeostasis and TIIDM: Aleglitazar, a PPARα and PPARγ agonist, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 7/June/2019, 11.30 pm
Molecular therapy for body weight control, energy homeostasis and TIIDM: Aleglitazar, a PPARα and PPARγ agonist, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 7/June/2019, 11.30 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say  A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator of adipose insulin resistance.”…

read more

Why Chronic stress-induced depression is not good for your heart: Mechanistic insights into chronic stress-induced depression may accelerate cardiac dysfunction: Chronic stress-induced depression augments DNA damage responses, attenuates telomerase expression, promotes telomere shortening, and attenuates cardiomyocyte survival after myocardial infarction, via down regulation of PNUTS, 7/June/2018, 11.01 pm
Why Chronic stress-induced depression is not good for your heart: Mechanistic insights into chronic stress-induced depression may accelerate cardiac dysfunction: Chronic stress-induced depression augments DNA damage responses, attenuates telomerase expression, promotes telomere shortening, and attenuates cardiomyocyte survival after myocardial infarction, via down regulation of PNUTS, 7/June/2018, 11.01 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of of the journal Nature,  by Prof Dimmler,…

read more

Sesame oil-derived compounds promote lifespan-extension: Sesamin/sesamol-based combinatorial therapy for Lifespan extension: A therapeutic mix encompassing Sesamin, sesamol, Melatonin, Ursolic acid, Maresin, DIM, Lutein, Ursolic acid  Lutein, Maresin, Cholecalciferol  Catalpol, Isoliquiritigenin (SSMUMDLCCI) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via upregulation of its target gene ATG5 (Autophagy-related 5), 6/June/2019, 11.24 pm
Sesame oil-derived compounds promote lifespan-extension: Sesamin/sesamol-based combinatorial therapy for Lifespan extension: A therapeutic mix encompassing Sesamin, sesamol, Melatonin, Ursolic acid, Maresin, DIM, Lutein, Ursolic acid  Lutein, Maresin, Cholecalciferol  Catalpol, Isoliquiritigenin (SSMUMDLCCI) activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via upregulation of its target gene ATG5 (Autophagy-related 5), 6/June/2019, 11.24 pm 1280 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was published, in the online…

read more

Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in chronic lymphocytic leukemia (CLL) and advanced metastatic cancers: A pharmaceutical mixture encompassing Venetoclax and Ibrutinib (VAI) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as TPM1, CADM1/2, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, and stalls CLL progression, via up-regulation of its target gene, 05/June/2019, `7.17 am
Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in chronic lymphocytic leukemia (CLL) and advanced metastatic cancers: A pharmaceutical mixture encompassing Venetoclax and Ibrutinib (VAI) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as TPM1, CADM1/2, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, and stalls CLL progression, via up-regulation of its target gene, 05/June/2019, `7.17 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the University of Texas M.D. Anderson Cancer Center, Houston, USA shows that “Ibrutinib and Venetoclax for First-Line Treatment of CLL.” This research paper was published, in…

read more

Curing diabetes with Liraglutide: Liraglutide-based therapy for TIIDM and obesity-associated metabolic deficits: Liraglutide (trade name:Victoza, Saxenda), a glucagon-like peptide-1 agonist used in the treatment of diabetes, increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, decreases TXNIP expression, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM, via down-regulation of its target gene, 04/June/2019, 12.14 pm
Curing diabetes with Liraglutide: Liraglutide-based therapy for TIIDM and obesity-associated metabolic deficits: Liraglutide (trade name:Victoza, Saxenda), a glucagon-like peptide-1 agonist used in the treatment of diabetes, increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, decreases TXNIP expression, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM, via down-regulation of its target gene, 04/June/2019, 12.14 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Physiology-Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA shows that “MC4R-dependent suppression of appetite by…

read more
Start Typing